UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

The Trump administration announced last week that it was cancelling nearly 10,000 foreign aid grants and contracts worth ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...

HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...

A groundbreaking SAMRC study has uncovered significant underreporting of HIV-related deaths in South Africa, despite the ...